Navigation Links
Third Wave wins triple damages in patent case

A federal judge has tripled Third Wave Technologies' compensation in a patent lawsuit with rival Stratagene to $15.9 million plus legal fees. Stratagene is proceeding with its appeal.

The lawsuit was decided in September after the judge found that Stratagene willfully infringed on two patents covering molecular diagn......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 12/19/05


Page: 1

Related biology technology :

1. Third Wave files countersuit vs. Digene in patent case
2. Third Wave reports net loss of $18.9M for 2006
3. Stratagene to pay Third Wave $10.75M in patent case
4. Third Wave responds to Digene patent lawsuit
5. Third Wave seeks approval of Cystic Fibrosis test
6. Third Wave Technologies to raise $14.9M through private debt
7. Third Wave reports $5.2M third quarter loss
8. Third Wave reports another loss, stronger sales
9. Napier joins board of Third Wave Technologies
10. Third Waves revenues rebound
11. Third Wave reports clinical growth, continued loss
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Third Wave wins triple damages patent case

(Date:12/3/2009)... ACCESS PHARMACEUTICALS, INC. ... on its European commercial launch of MuGard, an FDA ... of radiation treatment and chemotherapy. MuGard is commercially launched ... the UK, Germany, Italy, Norway, Greece and Sweden. Access ...
(Date:12/3/2009)... Medical Innovations, Inc. (NYSE: IMA ), a global ... at home through the merger of rapid diagnostics and health ... its Series B Convertible Perpetual Preferred Stock ( IMA-PB). The ... in an amount per share equal to the quotient of ...
(Date:12/2/2009)... 2 Spectrum Blue Steel is emerging as one of ... the efforts of True Green Energy Group and True Green ... in the recycling business for over 25 years, stated that ... is setting the stage for spectacular earnings because of the ...
(Date:12/2/2009)... Nearly 600 medical research executives, scientists, policy makers, ... and innovative funding strategies at the inaugural Partnering ... the Washington-based center of the Milken Institute, convened ... to turn a scientific discovery into an accessible therapy. ...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
... SAN DIEGO, June 18 Halozyme Therapeutics,Inc. (Nasdaq: ... products targeting the extracellular matrix, today,announced that it ... to be held in New York on June ... and Chief Executive Officer,will present on Wednesday, June ...
... June 18 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX:,MS), a ... today,announced that Mr. Kevin Giese, President and CEO, will ... York., WHEN: Wednesday June 25th ... New York, About the Jefferies 2nd Annual Healthcare ...
... BCRX ) today announced that William P. ... of BioCryst, effective July 1,2008. Dr. Sheridan is ... President of North American Medical Affairs at Amgen, ... Simon, who has been with,the Company since January ...
Other Biology Technology:Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference 2BioMS Medical to present at Jefferies Healthcare Conference 2William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals 2William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals 3William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals 4
(Date:12/3/2009)... of scientists from the U.S. Department of Energy,s (DOE) ... of Science has made a major step in understanding ... is necessary to carry out important biological processes. The ... Nature Structural & Molecular Biology , confirms that ...
(Date:12/2/2009)... PHILADELPHIA Less acculturated Latino men have a more ... acculturated to U.S. culture, but acculturation has no affect ... findings are published in Cancer Epidemiology, Biomarkers & ... Cancer Research. The December issue has a special focus ...
(Date:12/2/2009)... within minutes after waking up have much higher levels of ... than those who wait to smoke, regardless of the number ... appear to reflect the risk of lung cancer, our results ... especially at risk for lung cancer," said researcher Joshua E. ...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Acculturation affects smoking cessation success among Latinos 2Increased nicotine levels detected in those who light-up earlier 2Selexis and Neogenix Oncology Announce Agreement on Antibody Project 57950 1Selexis and Neogenix Oncology Announce Agreement on Antibody Project 57950 2TrinityCare Senior Living Announces Expansion into Louisiana 57948 1TrinityCare Senior Living Announces Expansion into Louisiana 57948 2TrinityCare Senior Living Announces Expansion into Louisiana 57948 3Moroney 26 Gill Inc Launches New Website 57946 1
... A. Rosenberg, M.D., at the National Cancer Institute, part ... patients with advanced melanoma who had not responded to ... of their cancers as a result of receiving a ... chemotherapy and reintroduction of their own (autologous) activated lymphocytes. ...
... have found that the cause of chronic sinus infections lies ... the nasal and sinus tissue targeted by standard treatment. The ... of Allergy and Clinical Immunology and are available online ... worldwide about the origin of chronic sinus infection: that inflammatory ...
... A new method for manipulating macromolecules has been developed ... The technique uses double-stranded DNA to direct the behavior ... duplex DNA has been used as a static lattice ... manipulating DNA alone into such shapes, the researchers are ...
Other Biology News:NCI Researchers Confirm the Effectiveness of Immunotherapy Approach to Treating Melanoma 2Chronic Sinus Infection Thought To Be Tissue Issue, Mayo Clinic Scientists Show It's Snot 2UN successfully tests 'green' pesticide against locusts 2
Rat polyclonal to acetyl Salicylic Acid ( Abpromise for all tested applications)....
Mouse monoclonal [DJR3] to DcR1 (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
GBL Antibody...
Human acetylcholine receptor (AChR)-alpha. Exhibits homogenous, high affinity,binding to the receptor. Binds weakly to a64-78. Inhibits binding of many,myasthenia gravis sera to human AChR....
Biology Products: